Actos and Nephrogenic anaemia - a phase IV clinical study of FDA data
Nephrogenic anaemia is found among people who take Actos, especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Actos and have Nephrogenic anaemia. It is created by eHealthMe based on reports of 48,451 people who have side effects when taking Actos from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
48,451 people reported to have side effects when taking Actos.
Among them, 237 people (0.49%) have Nephrogenic anaemia.
What is Actos?
Actos has active ingredients of pioglitazone hydrochloride. It is often used in diabetes. eHealthMe is studying from 49,109 Actos users for its effectiveness, alternative drugs and more.
What is Nephrogenic anaemia?
Nephrogenic anaemia (anaemia due to kidney disease) is found to be associated with 972 drugs and 425 conditions by eHealthMe.
Number of Actos and Nephrogenic anaemia reports submitted per year:
Time on Actos when people have Nephrogenic anaemia *:
Gender of people who have Nephrogenic anaemia when taking Actos*:
Age of people who have Nephrogenic anaemia when taking Actos *:
Common drugs people take besides Actos *:
Common side effects people have besides Nephrogenic anaemia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Actos and have Nephrogenic anaemia?Check whether Nephrogenic anaemia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Nephrogenic anaemia and when was it recovered:
Expand to all the drugs that have ingredients of pioglitazone hydrochloride:
Alternative drugs to, pros and cons of Actos:
- Actos (49,109 reports)
Common Actos side effects:
Browse all side effects of Actos:a b c d e f g h i j k l m n o p q r s t u v w x y z
Nephrogenic anaemia treatments and more:
- Nephrogenic anaemia (19,543 reports)
COVID vaccines that are related to Nephrogenic anaemia:
- Nephrogenic anaemia in Moderna COVID Vaccine
- Nephrogenic anaemia in Pfizer BioNTech Covid Vaccine
- Nephrogenic anaemia in Johnson and Johnson Covid Vaccine
Common drugs associated with Nephrogenic anaemia:
All the drugs that are associated with Nephrogenic anaemia:
- Nephrogenic anaemia (972 drugs)
Common conditions associated with Nephrogenic anaemia:
All the conditions that are associated with Nephrogenic anaemia:
- Nephrogenic anaemia (425 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on pioglitazone hydrochloride (the active ingredients of Actos) and Actos (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Mycophenolate Mofetil and Bumetanide drug interaction - 4 seconds ago
- Cabometyx and Herniated Nucleus Pulposus (Slipped Disk) - 8 seconds ago
- Tramadol Hydrochloride and Sotalol Hydrochloride drug interaction - 13 seconds ago
- Probiotic and Headache - 14 seconds ago
- Deferoxamine Mesylate and Weakness - 17 seconds ago
- Valsartan vs. Spironolactone - 39 seconds ago
- Ergocalciferol and Bumetanide drug interaction - 43 seconds ago
- Ortho Cyclen-28 and Vaginal Bleeding Between Periods - 53 seconds ago
- Omniscan and Clostridium Difficile Colitis - a minute ago
- Captopril and Adverse Event - a minute ago